ABSTRACT Background: The ectopic pelvic kidney, a common renal anomaly, is often smaller and malformed, with a shorter and sometimes tortuous ureter (1). Muscle-invasive bladder cancer (MIBC), constituting 15-25% of bladder cancer cases (2), mandates radical cystectomy with a 50% 5-year survival rate (2). Despite the growing use of robot-assisted radical cystectomy (RARC) (3, 4), there is limited data on its application in ectopic kidneys. Only one RARC case has been reported (5), in contrast to numerous open radical cystectomies (1, 6) involving an ectopic kidney. Patient and methods: After being diagnosed with T2 high-grade urothelial carcinoma, the 66-year-old patient, previously treated with multiple transurethral resections and adjuvant BCG therapy, received neoadjuvant chemotherapy. Preoperative staging CT revealed a 2.6 x 2.2 cm bladder neoformation and an ectopic right pelvic kidney. Results: Using the da Vinci Surgical System, radical cystectomy with ileal conduit (sec Wallace II) and lymphadenectomy were performed. During the demolition phase, the shorter right ureter was dissected with care to avoid damage to the renal pedicle. The reconstructive phase included intracorporeal urinary diversion (ICUD) and uretero-ileal anastomosis, facilitated by the favorable position of the kidney. The 8-hour console surgery resulted in minimal blood loss. Discharged on day 16 due to COVID-19, the patient exhibited positive outcomes. A 2-month CT follow-up revealed no cancer recurrence, metastasis, hydronephrosis, and complete regression of the lymphocele. Imaging follow-up continues without postoperative adjuvant chemotherapy. Conclusion: Robotic surgery with intracorporeal urinary diversion holds potential for right-sided pelvic kidney cases, but additional studies are necessary for validation. Background anomaly malformed 1. 1 . (1) Muscleinvasive Muscle invasive MIBC, MIBC , (MIBC) 1525% 1525 15 25% 25 15-25 2, 2 (2) 50 5year year 5 2. robotassisted robot assisted (RARC 3, 3 (3 4, 4 4) kidneys 5, (5) 1, (1 6 methods T highgrade high grade carcinoma 66yearold yearold 66 old therapy chemotherapy 26 22 Results System sec II performed pedicle ICUD (ICUD ureteroileal uretero anastomosis 8hour hour 8 loss COVID19, COVID19 COVID 19, 19 COVID-19 outcomes 2month month followup follow up recurrence metastasis hydronephrosis lymphocele Conclusion rightsided sided validation (MIBC 152 15-2 (2 ( (5 COVID1 COVID-1 15- COVID-